Spanish Red Biotech Pipeline

Amgen

tarlatamab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Respiratory and Pulmonary system
Indication: Relapsed/refractory small cell lung cancer
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I in Spain